Upload
others
View
0
Download
0
Embed Size (px)
Citation preview
Universitätsklinik für Frauenheilkunde | 211
WISSENSCHAFTLICHE
PUBLIKATIONEN
2014
212 | Universitätsklinik für Frauenheilkunde
Aust S, Auer K, Bachmayr-Heyda A, Denkert C, Sehouli
J, Braicu I, Mahner S, Lambrechts S, Vergote I, Grimm C,
Horvat R, Castillo-Tong DC, Zeillinger R, Pils D
Ambivalent role of pFAK-Y397 in serous ovarian cancer--a
study of the OVCAD consortium.
Mol Cancer. 2014; Mar 21;13:67 IF: 5,397
Aust S, Pils D
Epithelial ovarian cancer - more data, more questions?
Wien Med Wochenschr. 2014; Nov;164(21-22):479-86
IF: 0,791
Bader Y, Helmy S, Promberger R, Marschalek J, Jirecek
S, Jaksch P, Ott J
Hormonal contraception in female lung transplant recipi-
ents: a case series.
J Fam Plann Reprod Health Care. 2014; Oct;40(4):294-6
IF: 2,236
Lindorfer H, Krebs M, Kautzky-Willer A, Bancher-Todesca
D, Sager M, Gessl A
Iodine deficiency in pregnant women in Austria.
Eur J Clin Nutr. 2014; Dec10:1-6 IF: 2,950
Woitek R, Dvorak A, Weber M, Seidl R, Bettelheim D,
Schöpf V, Amann G, Brugger PC, Furtner J, Asenbaum U,
Prayer D, Kasprian G
MR-based morphometry of the posterior fossa in fetuses
with neural tube defects of the spine.
PLoS One. 2014; Nov 13;9(11):e112585 IF: 3,534
Kienzl D, Berger-Kulemann V, Kasprian G, Brugger PC,
Weber M, Bettelheim D, Pusch F, Prayer D
Risk of inferior vena cava compression syndrome during
fetal MRI in the supine position - a retrospective analysis.
J Perinat Med. 2014; May;42(3):301-6 IF: 1,425
Dörfler D, Kölle D
Alibi oder Wirklichkeit: Sexualität und Urogynäkologie
Geburtsh Frauenheilk. 2014;74:714-716 IF: 0,962
Schlembach D, Mörtl MG, Girard T, Arzt W, Beinder E, Bre-
zinka C, Chalubinski K, Fries D, Gogarten W, Hackelö-
er BJ, Helmer H, Henrich W, Hösli I, Husslein P, Kainer
F, Lang U, Pfanner G, Rath W, Schleussner E, Steiner H,
Surbek D, Zimmermann R
Management of postpartum hemorrhage (PPH): algorithm
of the interdisciplinary D-A-CH consensus group PPH (Ger-
many - Austria - Switzerland).
Anaesthesist. 2014; Mar;63(3):234-42 IF: 0,743
Braicu EI, Luketina H, Richter R, Cacsire Castillo-Tong D,
Lambrechts S, Mahner S, Concin N, Mentze M, Zeillinger
R, Vergote I, Sehouli J
HIF1α is an independent prognostic factor for overall survi-
val in advanced primary epithelial ovarian cancer - a study
of the OVCAD Consortium.
Onco Targets Ther. 2014; Sep 11;7:1563-9 IF: 1,342
Castillo-Tong DC, Pils D, Heinze G, Braicu I, Sehouli J,
Reinthaller A, Schuster E, Wolf A, Watrowski R, Maki
RA, Zeillinger R, Reynolds WF
Association of myeloperoxidase with ovarian cancer.
Tumour Biol. 2014; Jan;35(1):141-8 IF: 2,840
Despierre E, Moisse M, Yesilyurt B, Sehouli J, Braicu I,
Mahner S, Castillo-Tong DC, Zeillinger R, Lambrechts
S, Leunen K, Amant F, Moerman P, Lambrechts D, Ver-
gote I
Somatic copy number alterations predict response to plati-
num therapy in epithelial ovarian cancer.
Gynecol Oncol. 2014; Dec;135(3):415-22 IF: 3,687
Farr A, Bader Y, Husslein P, Györi G, Mühlbacher F, Mar-
greiter M
Ultra-high-risk pregnancies in women after renal transplan-
tation.
Eur J Obstet Gynecol Reprod Biol. 2014; Sep;180:72-6
IF: 1,627
Farr A, Györi G, Mühlbacher F, Husslein P, Böhmig GA,
Margreiter M
Gender has no influence on VUR rates after renal trans-
plantation.
Transpl Int. 2014; Nov;27(11):1152-8 IF: 3,120
Feichtinger M, Stopp T, Göbl C, Feichtinger E, Vaccari
E, Mädl U, Laccone F, Neesen J, Stroh-Weigert M, Hengst-
schläger M, Feichtinger W
Pregnancy rates after preimplantation genetic diagnoses
on polar bodies using CGH
Hum Rep. 2014; 29(1) IF: 4,585
Biadasiewicz K, Fock V, Dekan S, Proestling K, Velicky
P, Haider S, Knöfler M, Fröhlich C, Pollheimer J
Extravillous trophoblast-associated ADAM12 exerts pro-
invasive properties, including induction of integrin beta
1-mediated cellular spreading.
Biol Reprod. 2014; May;90(5):101 IF: 3,451
Friesenhengst A, Pribitzer-Winner T, Schreiber M
Association of the G473A Polymorphism and Expression
of Lysyl Oxidase with Breast Cancer Risk and Survival in
European Women: A Hospital-Based Case-Control Study.
PLoS ONE. 2014; Aug;9(8):e105579 IF: 3,534
Göbl CS, Bozkurt L, Yarragudi R, Tura A, Pacini G, Kautzky-
Willer A
Is early postpartum HbA1c an appropriate risk predictor
after pregnancy with Gestational Diabetes Mellitus?
Acta Diabetol. 2014; Oct;51(5): 715-22 IF: 3,679
Universitätsklinik für Frauenheilkunde | 213
Göbl CS, Bozkurt L, Yarragudi R, Prikoszovich T, Tura A,
Pacini G, Kautzky-Willer A
Biomarkers of endothelial dysfunction in relation to im-
paired carbohydrate metabolism after pregnancy with Ge-
stational Diabetes Mellitus.
Cardiovasc Diabetol. 2014; Oct 4;13(1):138 IF: 3,706
Stadler M, Krssak M, Jankovic D, Göbl C, Winhofer Y, Paci-
ni G, Bischof M, Haidinger M, Saemann M, Mühlbacher F,
Luger A, Prager R, Anderwald C, Krebs M
Effects of systematic insulin release on liver glycogen me-
tabolism in type-1 diabetic patients after successful pan-
creas kidney transplantation.
Clin Endocrinol (Oxf.) 2014; Feb;80(2):208–213 IF: 3,353
Göbl CS, Bozkurt L, Yarragudi R, Prikoszovich T, Tura A,
Pacini G, Kautzky-Willer A
Biomarkers of endothelial dysfunction in relation to im-
paired carbohydrate metabolism after pregnancy with Ge-
stational Diabetes Mellitus.
Diabetologia. 2014;57(Suppl1):456 IF: 6,880
Göbl CS, Bozkurt L, Yarragudi R, Prikoszovich T, Haumer
M, Tura A, Pacini G, Koppensteiner R, Kautzky-Willer A
Biomarkers of endothelial dysfunction in relation to im-
paired carbohydrate metabolism following pregnancy with
Gestational Diabetes Mellitus.
Wien Klin Wochenschr. 2014;126(4 Suppl):188 IF: 0,791
Göbl CS, Ott J, Bozkurt L, Rehmann V, Kern L, Howorka N,
Leitner K, Kurz C, Egarter C, Kautzky-Willer A
Assessment of insulin resistance and insulin secretion in
normal glucose toleran European females with PCOS
Wien Klin Wochenschr. 2014;126(4 Suppl):188 IF: 0,791
Bozkurt L, Göbl CS, Leitner K, Pfligl L, Hörmayer T, Luger
A, Baumgartner-Parzer S, Kautzky-Willer A
Insulin sensitivity and β-cell dysfunction among women
with early and late manifestation of GDM and those with
normal glucose tolerance according tot he IADPSG criteria.
Wien Klin Wochenschr. 2014;126(4 Suppl):192 IF: 0,791
Ataseven B, Grimm C, Harter P, Prader S, Traut A, Heitz
F, du Bois A
Prognostic value of lymph node ratio in patients with ad-
vanced epithelial ovarian cancer.
Gynecol Oncol. 2014; Dec;135(3):435-40 IF: 3,687
Grimm C, Polterauer S, Helmy S, Cibula D, Zikan M,
Reinthaller A, Tempfer C
A collagen-fibrin patch (Tachosil®) for the prevention of
symptomatic lymphoceles after pelvic lymphadenectomy
in women with gynecologic malignancies: a randomized
clinical trial.
BMC Cancer. 2014; Aug 30;14:635 IF: 3,319
Haider S, Meinhardt G, Velicky P, Otti GR, Whitley G,
Fiala C, Pollheimer J, Knöfler M
Notch signaling plays a critical role in motility and differen-
tiation of human first-trimester cytotrophoblasts.
Endocrinology. 2014; Jan;155(1):263-74 IF: 4,644
Aigmüller T, Tammaa A, Tamussino K, Hanzal E, Umek W,
Kölle D, Kropshofer S, Bjelic-Radisic V, Haas J, Giuliani A,
Lang PF, Preyer O, Peschers U, Jundt K, Ralph G, Dungl A,
Riss PA
Austrian TVT vs. TVT-O Study Group. Retropubic vs. tran-
sobturator tension-free vaginal tape for female stress uri-
nary incontinence: 3-month results of a randomized cont-
rolled trial.
Int Urogynecol J. 2014; Aug;25(8):1023-30 IF: 2,161
Wisgrill L, Schüller S, Bammer M, Berger A, Pollak A, Radke
TF, Kögler G, Spittler A, Helmer H, Husslein P, Gortner L
Hematopoietic stem cells in neonates: any differences bet-
ween very preterm and term neonates?
PLoS One. 2014; Sep 2;9(9):1-9, e106717 IF: 3,534
Helmy S, Bader Y, Pablik E, Tiringer D, Pils S, Laml T,
Kölbl H, Koch M
Cut-Off Value of Initial Serum Beta-Hcg Level Predicting a
Successful Mtx Therapy in Tubal Ectopic Pregnancy: A Re-
trospective Cohort Study.
Eur J Obstet Gynecol Reprod Biol. 2014; 179:175-80
IF: 1,627
Groten T, Schleussner E, Lehmann T, Reister F, Holzer B,
Danso KA, Zeillinger R
eNOSI4 and EPHX1 polymorphisms affect maternal su-
sceptibility to preeclampsia: analysis of five polymorphisms
predisposing to cardiovascular disease in 279 Caucasian
and 241 African women.
Arch Gynecol Obstet. 2014; Mar;289(3):581-93
IF: 1,279
Husslein H, Gutschi M, Leipold H, Herbst C, Franz M,
Worda C
Suture Closure versus Non-Closure of Subcutaneous Fat
and Cosmetic Outcome after Cesarean. Section: A Rando-
mized Controlled Trial.
PLoS One. 2014; Dec 10;9 IF: 3,534
Schneider K T M, Butterwegge M, Daumer M, Dudenhau-
sen J, Gonser M, Husslein P, Hecher K, Jensen A, Rath W,
Schiermeier S, Schmidt S, Vetter K, Zimmermann R; Ger-
man Society of Gynecology and Obstetrics (DGGG), Mater-
nal fetal Medicin Study Group (AGMFM), German Society
of Prenatal Medicine and Obstetrics (DGPGM)
S1 – Guideline on the Use of CTG During Pregnancy and
Labor
Geburtsh Frauenheilk. 2014; 74:721-732 IF: 0,962
214 | Universitätsklinik für Frauenheilkunde
Jatzko B, Vytiska-Bistorfer E, Pawlik A, Promberger R,
Mayerhofer K, Ott J
The impact of thyroid function on intrauterine insemination
outcome--a retrospective analysis.
Reprod Biol Endocrinol. 2014; Apr 5;12:28 IF: 2,409
Bresse X, Goergen C, Prager B, Joura E
Universal vaccination with the quadrivalent HPV vaccine in
Austria: impact on virus circulation, public health and cost-
effectiveness analysis.
Expert Rev Pharmacoecon Outcomes Res. 2014; 14:269-81
IF: 1,870
Joura EA, Ault KA, Bosch FX, Brown D, Cuzick J, Ferris D,
Garland SM, Giuliano AR, Hernandez-Avila M, Huh W, Iver-
sen OE, Kjaer SK, Luna J, Miller D, Monsonego J, Munoz N,
Myers E, Paavonen J, Pitisuttithum P, Steben M, Wheeler
CM, Perez G, Saah A, Luxembourg A, Sings HL, Velicer C
Attribution of 12 high-risk human papillomavirus genotypes
to infection and cervical disease.
Cancer Epidemiol Biomarkers Prev. 2014;23:1997-2008
IF: 4,324
Alemany L, Saunier M, Tinoco L, Quirós B, Alvarado-Ca-
brero I, Alejo M, Joura EA, Maldonado P, Klaustermeier J,
Salmerón J, Bergeron C, Petry KU, Guimerà N, Clavero O,
Murillo R, Clavel C, Wain V, Geraets DT, Jach R, Cross P,
Carrilho C, Molina C, Shin HR, Mandys V, Nowakowski AM,
Vidal A, Lombardi L, Kitchener H, Sica AR, Magaña-León
C, Pawlita M, Quint W, Bravo IG, Muñoz N, de Sanjosé S,
Bosch FX; HPV VVAP study group
Large contribution of human papillomavirus in vaginal neo-
plastic lesions: a worldwide study in 597 samples.
Eur J Cancer. 2014;50:2846-54 IF: 4,819
Kaufmann U, Domig KJ, Lippitsch CI, Kraler M, Marscha-
lek J, Kneifel W, Kiss H, Petricevic L
Ability of an orally administered lactobacilli preparation to
improve the quality of the neovaginal microflora in male to
female transsexual women.
Eur J Obstet Gynecol Reprod Biol. 2014; Jan;172:102-5
IF: 1,627
Kranz GS, Hahn A, Kaufmann U, Küblböck M, Hummer A,
Ganger S, Seiger R, Winkler D, Swaab DF, Windischberger
C, Kasper S, Lanzenberger R
White matter microstructure in transsexuals and controls
investigated by diffusion tensor imaging.
J Neurosci. 2014; Nov 12;34(46):15466-75 IF: 6,747
Stein P, Baldinger P, Kaufmann U, Christina RM, Hahn A,
Höflich A, Kranz GS, Savli M, Wadsak W, Mitterhauser M,
Winkler D, Kasper S, Lanzenberger R
Relation of progesterone and DHEAS serum levels to
5-HT1A receptor binding potential in pre- and postmeno-
pausal women.
Psychoneuroendocrinology. 2014; Aug; 46:52-63 IF: 5,591
Kranz GS, Rami-Mark C, Kaufmann U, Baldinger P, Hahn
A, Höflich A, Savli M, Stein P, Wadsak W, Mitterhauser M,
Winkler D, Lanzenberger R, Kasper S
Effects of hormone replacement therapy on cerebral sero-
tonin-1A receptor binding in postmenopausal women exa-
mined with [carbonyl-¹¹C]WAY-100635.
Psychoneuroendocrinology. 2014; Jul;45:1-10 IF: 5,591
Kranz GS, Wadsak W, Kaufmann U, Savli M, Baldinger P,
Gryglewski G, Haeusler D, Spies M, Mitterhauser M, Kas-
per S, Lanzenberger R
High-dose testosterone treatment increases serotonin
transporter binding in transgender people.
Biological Psychiatry. 2014 IF: 9,472
Hahn A, Kranz GS, Küblböck M, Kaufmann U, Ganger S,
Hummer A, Seiger R, Spies M, Winkler D, Kasper S, Win-
dischberger C, Swaab D, Lanzenberger R
Structural connectivity networks of transgender people.
Cerebral Cortex. 2014; Sept 12 IF: 8,305
Domig K, Kiss H, Petricevic L, Viernstein H, Unger F, Kneifel W
Strategies for the evaluation and selection of potential va-
ginal probiotics from human sources: an exemplary study.
Benef Microbes. 2014; 27:1-10 IF: 1,500
Xie L, Mouillet JF, Chu T, Parks WT, Sadovsky E, Knöfler
M, Sadovsky Y
C19MC microRNAs regulate the migration of human tro-
phoblasts.
Endocrinology. 2014; Dec;155(12):4975-85 IF: 4,644
Liu H, Murthi P, Qin S, Kusuma GD, Borg AJ, Knöfler M,
Haslinger P, Manuelpillai U, Pertile MD, Abumaree M, Ka-
lionis B
A novel combination of homeobox genes is expressed in
mesenchymal chorionic stem/stromal cells in first trimes-
ter and term pregnancies.
Reprod Sci. 2014; Nov;21(11):1382-94 IF: 2,179
Koneczny I, Schulenburg A, Hudec X, Knöfler M, Holz-
mann K, Piazza G, Reynolds R, Valent P, Marian B
Autocrine fibroblast growth factor 18 signaling mediates
Wnt-dependent stimulation of CD44-positive human colo-
rectal adenoma cells.
Mol Carcinog. 2014; Mar 12 IF: 4,770
Borbely AU, Sandri S, Fernandes IR, Prado KM, Cardoso
EC, Correa-Silva S, Albuquerque R, Knöfler M, Beltrão-
Braga P, Campa A, Bevilacqua E
The term basal plate of the human placenta as a source of
functional extravillous trophoblast cells.
Reprod Biol Endocrinol. 2014; Jan 28;12:7 IF: 2,409
Borbely AU, Daher S, Ishigai MM, Mattar R, Sun SY, Knöf-
ler M, Bevilacqua E, Oliveira SF
Universitätsklinik für Frauenheilkunde | 215
Decorin and biglycan immunolocalization in non-villous
structures of healthy and pathological human placentas.
Histopathology. 2014; Apr;64(5):616-25 IF: 3,301
Küronya V, Miernik A, Stupar S, Kojovic V, Egydio P,
Schoenthaler M, Fahr C, Kuehhas F
International multicenter psychometric evaluation of pati-
ent reported outcome data for the treatment of Peyronie’s
disease
BJU Int. 2014; Oct 18 IF: 3,130
Kuessel L, Jaeger-Lansky A, Pateisky P, Rossberg N,
Schulz A, Schmitz A, Staudigl C, Wenzl R
Cytokeratin-19 as a Biomarker in Urine and in Serum for
the Diagnosis of Endometriosis--a Prospective Study.
Gynecol Endocrinol 2014; Jan;30(1):38-41 IF: 1,136
Kuessel L, Wild J, Haslacher H, Perkmann T, Ristl R, Zeis-
ler H, Schmid M
Urine and Serum Concentrations of Cytokeratin 19 in Pree-
clampsia.
Eur J Obstet Gynecol Reprod Biol 2014; Oct;18:311-5
IF: 1,627
Königsbrügge O, Langer M, Hayde M, Ay C, Pabinger I
Oral anticoagulation with rivaroxaban during pregnancy: a
case report.
Thromb Haemost. 2014; Dec;112(6):1323-4 IF: 5,760
Böttcher B*, Laterza RM*, Wildt L, Seufert RJ, Buhling KJ,
Singer CF, Hill W, Griffin P, Jilma B, Schulz M, Smith RP (*
first- co-authorship)
A first-in-human study of PDC31 (prostaglandin F2α recep-
tor inhibitor) in primary dysmenorrhea.
Hum Reprod. 2014; Nov;29(11):2465-73 IF: 4,585
Laterza RM, Sievert KD, de Ridder D, Vierhout ME, Haab
F, Cardozo L, van Kerrebroeck P, Cruz F, Kelleher C, Chapp-
le C, Espuña-Pons M, Koelbl H
Bladder function after radical hysterectomy for cervical
cancer.
Neurourol Urodyn. 2014; Feb 12 IF: 2,458
Pacher J, Brix E, Lehner R
The mode of delivery in patients with preeclampsia at term
subject to elective or emergency Cesarean section.
Arch Gynecol Obstet. 2014; Feb;289(2):263-7 IF: 1,279
Grill A, Olischar M, Weber M, Pollak A, Leitich H
Type of delivery onset has a significant impact on post-
natal mortality in preterm infants of less than 30 weeks‘
gestation.
Acta Paediatr. 2014; Jul;103(7):722-6 IF: 1,842
Mascilini F, Moruzzi C, Giansiracusa C, Guastafierro F, Sa-
velli L, De Meis L, Epstein E, Timor-Tritsch IE, Mailath-Po-
korny M, Ercoli A, Exacoustos C, Benacerraf BR, Valentin
L, Testa AC
Imaging in gynecological disease. 10: Clinical and ultra-
sound characteristics of decidualized endometriomas sur-
gically removed during pregnancy.
Ultrasound Obstet Gynecol. 2014; 44:354-360 IF: 3,140
Schuster C, Mildner M, Mairhofer M, Bauer W, Fiala C,
Prior M, Eppel W, Kolbus A, Tschachler E, Stingl G, Elbe-
Bürger A
Human embryonic epidermis contains a diverse Langerhans
cell precursor pool. Development. 2014; Feb;141(4):807-15
IF: 6,273
Marschalek J, Trofaier ML, Yerlikaya G, Hanzal E, Ko-
elbl H, Ott J, Umek W
Anatomic outcomes after pelvic-organ-prolapse surgery-
comparing uterine preservation with hysterectomy.
Eur J Obstet Gynecol Reprod Biol. 2014; Dec;183:33-6
IF: 1,627
Meinhardt G, Haider S, Haslinger P, Proestling K,
Fiala C, Pollheimer J, Knöfler M
Wnt-dependent T-cell factor-4 controls human etravillous
trophoblast motility.
Endocrinology. 2014; May;155(5):1908-20 IF: 4,644
Lamm W, Natter C, Schur S, Köstler WJ, Reinthaller A,
Krainer M, Grimm C, Horvath R, Amann G, Funovics P,
Brodowicz T, Polterauer S
Distinctive outcome in patients with non-uterine and uteri-
ne leiomyosarcoma.
BMC Cancer. 2014; Dec 18;14:981 IF: 3,319
Schoppmann SF, Ricken G, Ilhan-Mutlu A, Nirtl N, Streu-
bel B, Preusser M, Birner P
Downregulation of CIC does not associate with overex-
pression of ETV1 or MAP kinase pathway activation in gas-
trointestinal stromal tumors.
Cancer Invest. 2014; Aug;32(7):363-7 IF: 2,060
Nouri K, Walch K, Promberger R, Kurz C, Tempfer CB, Ott J
Severe haematoperitoneum caused by ovarian bleeding af-
ter transvaginal oocyte retrieval: A retrospective analysis
and systematic literature review.
Reprod Biomed Online. 2014; Dec;29(6):699-707
IF: 2,980
Nouri K, Huber D, Walch K, Promberger R, Buerkle B, Ott
J, Tempfer CB
Fertility awareness among medical and non-medical stu-
dents: a case-control study.
Reprod Biol Endocrinol. 2014; Sep 26;12:94 IF: 2,409
Nouri K, Tempfer CB, Lenart C, Windischbauer L, Walch
K, Promberger R, Ott J
216 | Universitätsklinik für Frauenheilkunde
Predictive factors for recovery time in patients suffering
from severe OHSS.
Reprod Biol Endocrinol. 2014; Jul 5;12:59 IF: 2,409
Nouri K, Litschauer B, Sator M, Tiringer D, Ott J, Walch
K, Hefler LA, Tempfer CB Decline of semen quality during
IVF is not associated with subjective male stress.
Asian J Androl. 2014; Jul-Aug;16(4):597-601 IF: 2,530
Nouri K, Haslinger P, Szabo L, Sator M, Schreiber M,
Schneeberger C, Pietrowski D
Polymorphisms of VEGF and VEGF receptors are associa-
ted with the occurrence of ovarian hyperstimulation syn-
drome (OHSS)-a retrospective case-control study.
J Ovarian Res. 2014; May 13;7:54 IF: 2,030
Donnez J, Vázquez F, Tomaszewski J, Nouri K, Bouchard P, Fauser BC, Barlow DH, Palacios S, Donnez O, Bestel E, Osterloh I, Loumaye E; PEARL III and PEARL III Extension Study GroupLong-term treatment of uterine fibroids with ulipristal ace-tate. Fertil Steril. 2014; Jun;101(6):1565-73.e1-18 IF: 4,295
Ott J, Pecnik P, Promberger R, Pils S, Seemann R, Her-mann M, Frigo P
Dehydroepiandrosterone in women with premature ovarian failure and Hashimoto‘s thyroiditis.Climacteric. 2014; Feb;17(1):92-6 IF: 2,244
Promberger R, Ott J, Bures C, Kober F, Freissmuth M, See-mann R, Hermann MCan a surgeon predict the risk of postoperative hypopara-thyroidism during thyroid surgery? A prospective study on self-assessment by experts.Am J Surg. 2014; Jul;208(1):13-20 IF: 2,406
Ott J, Mayerhofer K, Nouri K, Walch K, Seemann R, Kurz C
Perioperative androstenedione kinetics in women undergo-ing laparoscopic ovarian drilling: a prospective study.Endocrine. 2014; Dec;47(3):936-42 IF: 3,527
Ott J, Kurz C, Braun R, Promberger R, Seemann R, Vytis-
ka-Binstorfer E, Walch K
Overt hypothyroidism is associated with the presence of uterine leiomyoma: a retrospective analysisEur J Obstet Gynecol Reprod Biol. 2014; Jun;177:19-22 IF: 1,627
Promberger R, Hermann M, Pallikunnel SJ, Seemann R, Meusel M, Ott J
Quality of life after thyroid surgery in women with benign euthyroid goiter: influencing factors including Hashimoto‘s thyroiditis.Am J Surg. 2014; Jun;207(6):974-9 IF: 2,406
Otti GR, Saleh L, Velicky P, Fiala C, Pollheimer J, Knöfler M
Notch2 controls prolactin and insulin-like growth factor binding protein-1 expression in decidualizing human stro-mal cells of early pregnancy. PLoS One. 2014; Nov 14;9(11):e112723 IF: 3,534
Petricevic L, Kaufmann U, Domig KJ, Kraler M, Mar-
schalek J, Kneifel W, Kiss H
Rectal Lactobacillus species and their influence on the vaginal microflora: a model of male-to-female transsexual women.J Sex Med. 2014; Nov;11(11):2738-43 IF: 3,150
Petricevic L, Kaufmann U, Domig KJ, Kraler M, Mar-
schalek J, Kneifel W, Kiss H
Molecular detection of Lactobacillus species in the neova-gina of male-to-female transsexual women.Sci Rep. 2014; Jan 17;4:3746 IF: 5,078
Petricevic L, Domig K, Nierscher F, Sandhofer M, Fides-ser M, Kronhofer I, Husslein P, Kneifel W, Kiss H
Characterisation of the vaginal Lactobacillus microbiota associates with preterm delivery.Scientific Report. 2014; 4:5136 IF: 5,078
Groessl M, Slany A, Bileck A, Gloessmann K, Kreutz D, Jae-ger W, Pfeiler G, Gerner CProteome profiling of breast cancer biopsies reveals a wound healing signature of cancer-associated fibroblasts.J Proteome Res. 2014; Nov 7;13(11):4773-82 IF: 5,001
Pietrowski D, Gong Y, Mairhofer M, Gessele R, Sator M
Effects of Progesterone and its Metabolites on Human Gra-nulosa Cells. Horm Metab Res. 2014; Feb;46(2):133-7 IF: 2,038
Horak P, Tomasich E, Vaňhara P, Kratochvílová K, Anees M, Marhold M, Lemberger CE, Gerschpacher M, Horvat R, Sibilia M, Pils D, Krainer MTUSC3 loss alters the ER stress response and accelerates prostate cancer growth in vivo. Sci Rep. 2014; Jan 17;4:3739 IF: 5,078
Pils D, Bachmayr-Heyda A, Auer K, Svoboda M, Auner
V, Hager G, Obermayr E, Reiner A, Reinthaller A, Spei-
ser P, Braicu I, Sehouli J, Lambrechts S, Vergote I, Mahner S, Berger A, Cacsire Castillo-Tong D, Zeillinger R
Cyclin E1 (CCNE1) as independent positive prognostic fac-tor in advanced stage serous ovarian cancer patients - a study of the OVCAD consortium. Eur J Cancer. 2014; Jan;50(1):99-110 IF: 4,819
Pavo N, Zimmermann M, Pils D, Mildner M, Petrási Z, Pet-neházy Ö, Fuzik J, Jakab A, Gabriel C, Sipos W, Maurer G, Gyöngyösi M, Ankersmit HJLong-acting beneficial effect of percutaneously intramyocar-
Universitätsklinik für Frauenheilkunde | 217
dially delivered secretome of apoptotic peripheral blood cells
on porcine chronic ischemic left ventricular dysfunction.
Biomaterials. 2014; Apr;35(11):3541-50 IF: 8,312
Pils S, Joura EA, Winter MP, Shrestha A, Jaeger-Lansky
A, Ott J
What do women with gynecologic cancer know about HPV
and their individual disease? A pilot study.
BMC Cancer. 2014; May 30;14:388 IF: 3,319
Pils S, Eppel W, Seemann R, Natter C, Ott J
Sequential cervical length screening in pregnancies after
loop excision of the transformation zone conisation: a ret-
rospective analysis.
BJOG. 2014; Mar;121(4):457-62 IF: 3,862
Pollheimer J, Fock V, Knöfler M
Invited Review: the ADAM metalloproteinases - novel regu-
lators of trophoblast invasion?
Placenta. 2014; Feb;35 Suppl:S57-63 IF: 3,285
Franz MB, Polterauer M, Elhenicky M, Stary S, Birner P,
Vinatzer U, Husslein P, Streubel B, Husslein H
Global and single gene DNA methylation in umbilical
cord blood cells after elective caesarean: a pilot study.
Eur J Obstet Gynecol Reprod Biol. 2014; Aug;179:121-4
IF: 1,627
Brammen L, Staudenherz A, Polterauer S, Dolliner P,
Grimm C, Reinthaller A, Sinzinger H
Sentinel lymph node detection in vulvar cancer patients: a
20 years analysis.
Hell J Nucl Med. 2014; Sep-Dec;17(3):184-9 IF: 0,925
Sehouli J, Reinthaller A, Marth C, Reimer D, Reimer T,
Stummvoll W, Angleitner-Boubenizek L, Brandt B, Chekerov R
Intra- and postoperative catumaxomab in patients with epi-
thelial ovarian cancer: safety and two-year efficacy results
from a multicentre, single-arm, phase II study.
Br J Cancer. 2014; Oct 14;111(8):1519-25 IF: 4,817
Vergote IB, Jimeno A, Joly F, Katsaros D, Coens C, De-
spierre E, Marth C, Hall M, Steer CB, Colombo N, Lesoin A,
Casado A, Reinthaller A, Green J, Buck M, Ray-Coquard
I, Ferrero A, Favier L, Reed NS, Curé H, Pujade-Lauraine E
Randomized phase III study of erlotinib versus observation
in patients with no evidence of disease progression after
first-line platin-based chemotherapy for ovarian carcino-
ma: a European Organisation for Research and Treatment
of Cancer-Gynaecological Cancer Group, and Gynecologic
Cancer Intergroup study.
J Clin Oncol. 2014; Feb 1;32(4):320-6 IF: 17,960
Rosta K, Hadarits O, Al-Aissa Z, List A, Feichtinger M,
Sziller I, Rigo J, Somogyi A, Firneisz G, Kautzky-Willer A,
Harreiter J, Bancher-Todesca D
VEGF und IL1RA Konzentrationen im Nabelschnurserum
von Frauen mit Gestationsdiabetes.
Geburtsh Frauenheilk. 2014; Ausgabe S01 IF: 0,962
Zins K, Mogg M, Schneeberger C, Abraham D, Schreiber M
Analysis of the rs10046 polymorphism of aromatase
(CYP19) in premenopausal onset of human breast cancer.
Int J Mol Sci. 2014; Jan;15(1):712-24 IF: 2,339
Csiszar A, Kutay B, Wirth S, Schmidt U, Macho-Maschler S,
Schreiber M, Alacakaptan M, Vogel GF, Aumayr K, Huber
LA, Beug H
Interleukin-like epithelial-to-mesenchymal transition in-
ducer activity is controlled by proteolytic processing and
plasminogen inverted question mark urokinase plasmino-
gen activator receptor system-regulated secretion during
breast cancer progression.
Breast cancer research. 2014; Sept;16(5):433 IF 5,881
Birner P, Bartsch R, Schreiber M, Dubsky P, Kenner L
New approaches for breast cancer: should Ret kinase be
considered as a novel therapeutic target?
Future Oncology. 2014; Feb;10(3):333-36 IF: 2,611
Schwameis R, Eder S, Pietschmann H, Fischer B, Mascher
H, Tzotzos S, Fischer H, Lucas R, Zeitlinger M, Hermann R
A FIM study to assess safety and exposure of inhaled single
doses of AP301-A specific ENaC channel activator for the
treatment of acute lung injury.
J Clin Pharmacol. 2014; Mar;54(3):341-50 IF: 2,472
Brämswig K, Ploner F, Martel A, Bauernhofer T, Hilbe W,
Kühr T, Leitgeb C, Mlineritsch B, Petzer A, Seebacher V,
Stöger H, Girschikofsky M, Hochreiner G, Ressler S, Rome-
der F, Wöll E, Brodowicz T
Sorafenib in advanced, heavily pretreated patients with
soft tissue sarcomas.
Anticancer Drugs. 2014; Aug;25(7):848-53 IF: 1,891
EBCTCG (Early Breast Cancer Trialists‘ Collaborative
Group), McGale P, Taylor C, Correa C, Cutter D, Duane F,
Ewertz M, Gray R, Mannu G, Peto R, Whelan T, Wang Y,
Wang Z, Darby S
Collaborateurs: Abe O, Abe R, Enomoto K, Kikuchi K, Koya-
ma H, Masuda H, Nomura Y, Ohashi Y, Sakai K, Sugimachi
K, Toi M, Tominaga T, Uchino J, Yoshida M, Haybittle JL, Leo-
nard CF, Calais G, Geraud P, Collett V, Davies C, Delmestri
A, Sayer J, Harvey VJ, Holdaway IM, Kay RG, Mason BH,
Forbes JF, Wilcken N, Bartsch R, Dubsky P, Fesl C, Fohler
H, Gnant M, Greil R, Jakesz R, Lang A, Luschin-Ebengreuth
G, Marth C, Mlineritsch B, Samonigg H, Singer CF, Steger
GG, Stöger H, Canney P, Yosef HM, Focan C, Peek U, Oates
GD, Powell J, Durand M, Mauriac L, Di Leo A, et al
Effect of radiotherapy after mastectomy and axillary sur-
gery on 10-year recurrence and 20-year breast cancer
mortality: meta-analysis of individual patient data for 8135
218 | Universitätsklinik für Frauenheilkunde
women in 22 randomised trials.
Lancet. 2014; Jun 21;383(9935):2127-35 IF: 39,207
Singer CF, Rappaport-Fuerhauser C, Sopik V, Narod SA
Prostate Cancer in a Man with a BRCA2 Mutation and a
Personal History of Bilateral Breast Cancer.
Clin Genet. 2014; Aug 12 IF: 3,652
Gronwald J, Robidoux A, Kim-Sing C, Tung N, Lynch HT,
Foulkes WD, Manoukian S, Ainsworth P, Neuhausen SL,
Demsky R, Eisen A, Singer CF, Saal H, Senter L, Eng C,
Weitzel J, Moller P, Gilchrist DM, Olopade O, Ginsburg O,
Sun P, Huzarski T, Lubinski J, Narod SA; Hereditary Breast
Cancer Clinical Study Group
Duration of tamoxifen use and the risk of contralateral
breast cancer in BRCA1 and BRCA2 mutation carriers.
Breast Cancer Res Treat. 2014; 146:421–427 IF: 4,198
Singer CF, Coelingh Bennink HJT, Natter C, Steurer S,
Rudas M, Moinfar F, Appels NRCA, Visser M and Kubista E
Anti-estrogenic effects of the fetal estrogen estetrol in wo-
men with estrogen-receptor positive early breast cancer.
Carcinogenesis. 2014; Nov;35(11):2447-51 IF: 5,266
Chai X, Friebel TM, Singer CF, Evans DG, Lynch HT, Isaacs
C, Garber JE, Neuhausen SL, Matloff E, Eeles R, Tung N,
Weitzel JN, Couch FJ, Hulick PJ, Ganz PA, Daly MB, Olopade
OI, Tomlinson G, Blum JL, Domchek SM, Chen J, Rebbeck TR
Use of risk-reducing surgeries in a prospective cohort of
1,499 BRCA1 and BRCA2 mutation carriers.
Breast Cancer Res Treat. 2014; Nov;148(2):397-406
IF: 4,198
Exner R, Bago-Horvath Z, Bartsch R, Mittlboeck M, Retèl
VP, Fitzal F, Rudas M, Singer C, Pfeiler G, Gnant M, Jakesz
R, Dubsky PThe multigene signature MammaPrint impacts
on multidisciplinary team decisions in ER+, HER2- early
breast cancer.
Br J Cancer. 2014; Aug 26,111(5):837-42 IF: 4,817
Gnant M, Filipits M, Greil R, Stoeger H, Rudas M, Bago-
Horvath Z, Mlineritsch B, Kwasny W, Knauer M, Singer C,
Jakesz R, Dubsky P, Fitzal F, Bartsch R, Steger G, Balic M,
Ressler S, Cowens JW, Storhoff J, Ferree S, Schaper C, Liu
S, Fesl C, Nielsen TO; on behalf of the Austrian Breast and
Colorectal Cancer Study Group
Predicting distant recurrence in receptor-positive breast
cancer patients with limited clinicopathological risk: using
the PAM50 Risk of Recurrence score in 1478 postmeno-
pausal patients of the ABCSG-8 trial treated with adjuvant
endocrine therapy alone.
Ann Oncol. 2014; Feb;25(2):339-45 IF: 6,578
Filipits M, Nielsen TO, Rudas M, Greil R, Stöger H, Jakesz R,
Bago-Horvath Z, Dietze O, Regitnig P, Gruber-Rossipal C,
Müller-Holzner E, Singer CF, Mlineritsch B, Dubsky P, Bau-
ernhofer T, Hubalek M, Knauer M, Trapl H, Fesl C, Schaper
C, Ferree S, Liu S, Cowens JW, Gnant M; for the Austrian
Breast and Colorectal Cancer Study Group
The PAM50 Risk-of-Recurrence Score Predicts Risk for
Late Distant Recurrence after Endocrine Therapy in Post-
menopausal Women with Endocrine-Responsive Early
Breast Cancer.
Clin Cancer Res. 2014; Mar 1;20(5):1298-305 IF: 8,193
Kotsopoulos J, Lubinski J, Moller P, Lynch HT, Singer CF,
Eng C, Neuhausen SL, Karlan B, Kim-Sing C, Huzarski T,
Gronwald J, McCuaig J, Senter L, Tung N, Ghadirian P, Eisen
A, Gilchrist D, Blum JL, Zakalik D, Pal T, Sun P, Narod SA;
Hereditary Breast Cancer Clinical Study Group
Timing of oral contraceptive use and the risk of breast can-
cer in BRCA1 mutation carriers.
Breast Cancer Res Treat. 2014; Feb; 143(3):579-86
IF: 4,198
Steger G, Greil R, Lang A, Rudas M, Fitzal F, Mlineritsch B,
Hartmann BL, Bartsch R, Melbinger E, Hubalek M, Stoeger H,
Dubsky P, Ressler S, Petzer AL, Singer CF, Muss C, Jakesz
R, Gampenrieder SP, Zielinski CC, Fesl C, Gnant M; on behalf
of the Austrian Breast and Colorectal Study Group (ABCSG)
Epirubicin and docetaxel with or without capecitabine as
neoadjuvant treatment for early breast cancer: final results
of a randomized phase III study (ABCSG-24).
Ann Oncol. 2014; Feb; 25(2):366-71 IF: 6,578
Fuchs EM, Köstler WJ, Horvat R, Hudelist G, Kubista E, At-
tems J, Zielinski CC, Singer CF
High-Level ERB2 Gene Amplification is Associated with a
Particularly Short Time-to-Metastasis (TTM), but Results
in a High Rate of Complete Response (CR) once Trastu-
zumab-based Therapy is Offered in the Metastatic Setting.
Int J Cancer. 2014; Jul 1; 135(1):224-31 IF: 5,007
Phelan CM, Iqbal J, Lynch HT, Lubinski J, Gronwald J, Moller
P, Ghadirian P, Foulkes WD, Armel S, Eisen A, Neuhausen
SL, Senter L, Singer CF, Ainsworth P, Kim-Sing C, Tung N,
Llacuachaqui M, Chornokur G, Ping S, Narod SA; Heredita-
ry Breast Cancer Study Group
Incidence of colorectal cancer in BRCA1 and BRCA2 muta-
tion carriers: results from a follow-up study.
Br J Cancer. 2014; Jan 21;110(2):530-4 IF: 4,817
Singer CF, Muhr D, Rappaport C, Tea M-K, Gschwant-
ler-Kaulich D, Fink-Retter A, Pfeiler G, Berger A, Sun P,
Narod SA
Clinical implications of genetic testing for BRCA1 and
BRCA2 mutations in Austria.
Clin Genet. 2014; Jan;85(1):72-5 IF: 3,652
Giannakeas V, Lubinski J, Gronwald J, Moller P, Armel S,
Lynch HT, Foulkes WD, Kim-Sing C, Singer C, Neuhausen
SL, Friedman E, Tung N, Senter L, Sun P, Narod SA
Universitätsklinik für Frauenheilkunde | 219
Mammography screening and the risk of breast cancer in
BRCA1 and BRCA2 mutation carriers: a prospective study.
Breast Cancer Res Treat. 2014; Aug;147(1):113-8
IF: 4,198
Bartova M, Ondrias F, Muy-Kheng T, Kastner M, Singer Ch,
Pohlodek K
COX-2, p16 and Ki67 expression in DCIS, microinvasive
and early invasive breast carcinoma with extensive intra-
ductal component.
Bratisl Lek Listy. 2014;115(7):445-51 IF: 0,470
Osorio A, Milne RL, Kuchenbaecker K, Vaclová T, Pita G, Alon-so R, Peterlongo P, Blanco I, De la Hoya M, Duran M, Díez O, Ramón y Cajal T, Konstantopoulou I, Martínez-Bouzas C, Co-
nejero RA, Soucy P, McGuffog L, Barrowdale D, Lee A, SWE-
BRCA, Arver B, Rantala J, Loman N, Ehrencrona H, Olopade OI,
Beattie MS, Domchek SM, Nathanson K, Rebbeck TR, Arun BK,
Karlan BY, Walsh C, Lester J, John EM, Whittemore AS, Daly MB,
Southey M, Hopper J, Terry MB, Buys SS, Janavicius R, Dorfling
CM, Van Rensburg EJ, Steele L, Neuhausen SL, Ding YC,
v. O. Hansen T, Jønson L, Ejlertsen B, Gerdes AM, Infante M,
Herráez B, Thais Moreno L, Weitzel JN, Herzog J, Weeman
K, Manoukian S, Peissel B, Zaffaroni D, Scuvera G, Bonan-
ni B, Mariette F, Volorio S, Viel A, Varesco L, Papi L, Ottini
L, Tibiletti MG, Radice P, Yannoukakos D, Garber J, Ellis S,
Frost D, Platte R, Fineberg E, Evans G, Lalloo F, Izatt L, Eeles
R, Adlard J, Davidson R, Cole T, Eccles D, Cook J, Hodgson
S, Brewer C, Tischkowitz M, Douglas F, Porteous M, Side L,
Walker L, Morrison P, Donaldson A, Kennedy J, Foo C, God-
win AK, Schmutzler RK, Wappenschmidt B, Rhiem K, Engel
C, Meindl A, Ditsch N, Arnold N, Plendl HJ, Niederacher D,
Sutter C, Wang-Gohrke SW, Steinemann D, Preisler-Adams
S, Kast K, Varon-Mateeva R, Gehrig A, Stoppa-Lyonnet D,
Sinilnikova OM, Mazoyer S, Damiola F, Poppe B, Claes K,
Piedmonte M, Tucker K, Backes F, Rodríguez G, Brewster W,
Wakeley K, Rutherford T, Caldés T, Nevanlinna H, Aittomä-
ki K, Rookus MA, Van Os TAM, Van der Kolk L, De Lange
JL, Meijers-Heijboer HEJ, Van der Hout AH, Van Asperen CJ,
Gómez Garcia EB, Hoogerbrugge N, Collée JM, Van Deurzen
CHM, Van der Luijt RB, Devilee P, HEBON, Olah E, Lázaro
C, Teulé A, Menéndez M, Jakubowska A, Cybulsk C, Gron-
wald J, Lubinski J, Durda K, Jaworska-Bieniek K, Johannsson
OTh, Maugard C, Montagna M, Tognazzo S, Teixeira MR,
Healey S, kConFab Investigators, Olswold C, Guidugli L, Lin-
dor N, Slager S, Szabo, Vijai CIJ, Robson M, Kauff N, Zhang
L, Rau-Murthy R, Fink-Retter A, Singer CF, Rappaport C,
Gschwantler Kaulich D, Pfeiler G, Tea MK, Berger A,
Phelan CM, Greene MH, Mai PL, Lejbkowicz F, Andrulis I,
Mulligan AM, Glendon G, Toland AE, Bojesen A, Pedersen IS,
Sunde L, Thomassen M, Kruse TA, Jensen UB, Friedman E,
Laitman Y, Shimon SP, Simard J, Easton DF, Offit K, Couch
FJ, Chenevix-Trench G, Antoniou AC, Benitez J
DNA Glycosylases Involved in Base Excision Repair May Be Asso-
ciated with Cancer Risk in BRCA1 and BRCA2 Mutation Carriers
PLoS Genet. 2014; Apr 3;10(4):e1004256 IF: 8,167
Finch APM, Lubinski J, Moller P, Singer CF, Karlan B, Senter L,
Rosen B, Maehle L, Ghadirian P, Cybulski C, Huzarski T, Eisen A,
Foulkes WD, Kim-Sing C, Ainsworth P, Tung N, HT Lynch, Neu-
hausen S, Metcalfe KA, Thompson I, Murphy J, Sun P, Narod S
Impact of Oophorectomy on Cancer Incidence and Mortali-
ty in Women with BRCA1 or BRCA2 Mutation.
J Clin Oncol. 2014; May 20;32(15):1547-53 IF: 17,960
Springer S, Mlczoch E, Krampl-Bettelheim E, Mailath-
Pokorny M, Ulm B, Worda C, Worda K
Congenital heart disease in monochorionic twins with and
without twin-to-twin transfusion syndrome.
Prenat Diagn. 2014; Oct;34(10):994-9 IF: 2,514
Staudigl C, Bartova M, Salama M, Dzagnidze G, Bago-
Horvath Z, Pohlodek K, Singer CF, Tea MM
Histopathological characterization of ulcerated breast can-
cer and comparison to their non-ulcerated counterparts.
Tumour Biol. 2014; Dec 28 IF: 2,840
Berghoff AS, Bartsch R, Wöhrer A, Streubel B, Birner P,
Kros JM, Brastianos
PK, von Deimling A, Preusser M
Predictive molecular markers in metastases to thecentral
nervous system: recent advances and future avenues.
Acta Neuropathol. 2014; Dec;128(6):879-91 IF: 9,777
Anees M, Horak P, Schiefer AI, Vaňhara P, El-Gazzar A,
Perco P, Kiesewetter B, Müllauer L, Streubel B, Raderer
M, Krainer M
The potential evasion of immune surveillance in mucosa
associated lymphoid tissue lymphoma by DcR2-mediated
up-regulation of nuclear factor-κB.
Leuk Lymphoma. 2014; Nov 5:1-10 IF: 2,605
Preusser M, Streubel B, Berghoff AS, Hainfellner JA, von
Deimling A, Widhalm
G, Dieckmann K, Wöhrer A, Hackl M, Zielinski C, Birner P
Amplification and overexpression of CMET is a common
event in brain metastases of non-small cell lung cancer.
Histopathology. 2014; Nov;65(5):684-92 IF: 3,301
Berghoff AS, Bartsch R, Preusser M, Ricken G, Steger GG,
Bago-Horvath Z, Rudas M, Streubel B, Dubsky P, Gnant
M, Fitzal F, Zielinski CC, Birner P
Co-overexpression of HER2/HER3 is a predictor of im-
paired survival in breast cancer patients.
Breast. 2014; Oct;23(5):637-43 IF: 2,581
Berghoff AS, Birner P, Streubel B, Kenner L, Preusser M
ALK gene aberrations and the JUN/JUNB/PDGFR axis in
metastatic NSCLC.
APMIS. 2014; Sep;122(9):867-72 IF: 1,922
Birner P, Pusch S, Christov C, Mihaylova S, Toumangelova-
Uzeir K, Natchev S, Schoppmann SF, Tchorbanov A, Streu-
220 | Universitätsklinik für Frauenheilkunde
bel B, Tuettenberg J, Guentchev M. Mutant IDH1 inhibits
PI3K/Akt signaling in human glioma.
Cancer. 2014; Aug 15;120(16):2440-7 IF: 4,901
Blatt K, Herrmann H, Hoermann G, Willmann M, Cerny-Rei-
terer S, Sadovnik I, Herndlhofer S, Streubel B, Rabitsch
W, Sperr WR, Mayerhofer M, Rülicke T, Valent P. Identifica-
tion of campath-1 (CD52) as novel drug target in neoplastic
stem
cells in 5q-patients with MDS and AML.
Clin Cancer Res. 2014; Jul 1;20(13):3589-602 IF: 8,193
Herrmann H, Sadovnik I, Cerny-Reiterer S, Rülicke T,
Stefanzl G, Willmann M, Hoermann G, Bilban M, Blatt K,
Herndlhofer S, Mayerhofer M, Streubel B, Sperr WR, Ho-
lyoake TL, Mannhalter C, Valent P
Dipeptidylpeptidase IV (CD26) defines leukemic stem cells
(LSC) in chronic myeloid leukemia.
Blood. 2014; Jun19;123(25):3951-62 IF: 9,775
Preusser M, Streubel B, Birner P
ROS1 translocations and amplifications in lung cancer
brain metastases.
J Neurooncol. 2014; Jun;118(2):425-6 IF: 2,787
Mitterbauer A, Hoetzenecker K, Birner P, Mildner M, Prosch
H, Streubel B, Taghavi S, Klepetko W, Ankersmit HJ
Clinical-radiological, histological and genetic analyses in a
lung transplant recipient with Mounier-Kuhn syndrome and
end-stage chronic obstructive pulmonary disease.
Clin Respir J. 2014; Apr 14 IF: 2,197
Birner P, Streubel B
Novel clinically relevant genes in GIST--response.
Clin Cancer Res. 2014; Apr 1;20(7):2014 IF: 8,193
Preusser M, Berghoff AS, Berger W, Ilhan-Mutlu A, Dinhof
C, Widhalm G, Dieckmann K, Wöhrer A, Hackl M, von Deim-
ling A, Streubel B, Birner P
High rate of FGFR1 amplifications in brain metastases of
squamous and non-squamous lung cancer.
Lung Cancer. 2014; Jan;83(1):83-9 IF: 3,737
Kiesewetter B, Lukas J, Kuchar A, Mayerhoefer ME, Streubel
B, Lagler H, Müllauer L, Wöhrer S, Fischbach J, Raderer M
Clinical features, treatment and outcome of mucosa-asso-
ciated lymphoid tissue (MALT) lymphoma of the ocular ad-
nexa: single center experience of 60 patients. PLoS One.
2014; Jul 31;9(7) IF: 3,534
Kaczirek K, Ciuleanu TE, Vrbanec D, Marton E, Messinger
D, Liegl-Atzwanger B, Wrba F, Knittelfelder R, Lindner E,
Zielinski CC, Streubel B, Brodowicz T
FOLFOX4 Plus Cetuximab for Patients With Previously Un-
treated Metastatic
Colorectal Cancer According to Tumor RAS and BRAF Mu-
tation Status: Updated
Analysis of the CECOG/CORE 1.2.002 Study
Clin Colorectal Cancer. 2014; Dec 24 IF: 2,907
Tea MK, Kroiss R, Muhr D, Fuerhauser-Rappaport C,
Oefner P, Wagner TM, Singer CF
Central European BRCA2 mutation carriers: Birth cohort
status correlates with onset of breast cancer.
Maturitas. 2014; Jan;77(1):68-72 IF: 2,861
Wagner G, Penelo E, Nobis G, Mayrhofer A, Wanner C,
Schau J, Spitzer M, Gwinner P, Trofaier ML, Imgart H,
Fernandez-Aranda F, Karwautz A
Predictors for Good Therapeutic Outcome and Drop-out in
Technology Assisted Guided Self-Help in the Treatment of
Bulimia Nervosa and Bulimia like Phenotype.
Eur Eat Disord Rev. 2014; Dec 1 IF: 2,252
Tunn R, Albrich S, Beilecke K, Kociszewski J, Lindig-Knop-
ke C, Reisenauer C, Schwertner-Tiepelmann N, Kuhn A,
Viereck V, Bjelic Radisic V, Kölle D, Umek W, Bader W,
Schwandner O, Lange R
Interdisciplinary S2k Guideline: Sonography in Urogyneco-
logy: Short Version - AWMF Registry Number: 015/055.
Geburtshilfe Frauenheilk. 2014; Dec;74(12):1093-1098
IF: 0,962
Bjelic-Radisic V, Aigmueller T, Preyer O, Ralph G, Geiss I,
Müller G, Riss P, Klug P, Konrad M, Wagner G, Medl M,
Umek W, Lozano P, Tamussino K, Tammaa A
Austrian Urogynecology Working Group. Vaginal prolapse sur-
gery with transvaginal mesh: results of the Austrian registry.
Int Urogynecol J. 2014; Aug;25(8):1047-52 IF: 2,161
Velicky P, Haider S, Otti GR, Fiala C, Pollheimer J,
Knöfler M
Notch-dependent RBPJκ inhibits proliferation of human
cytotrophoblasts and their differentiation into extravillous
trophoblasts.
Mol Hum Reprod. 2014; Aug;20(8):756-66 IF: 3,483
Baumgartner-Parzer S, Vytiska-Binsdorfer E, Kleinle S,
Heinze G, Vierhapper H
Unexplained infertility: increased risk for 21-hydroxylase-
deficiency in parents and offspring?
Eur J Obstet Gynecol Reprod Biol. 2014; Nov;182:258-9
(Letter to the Editor) IF:1,627
Walch K, Kernstock T, Poschalko-Hammerle G, Gleiß A,
Staudigl C, Wenzl R Prevalence and severity of cyclic leg
pain in women with endometriosis and in controls - effect
of laparoscopic surgery.
Eur J Obstet Gynecol Reprod Biol. 2014; Aug;179:51-7
IF: 1,627
Kushnir VA, Yu Y, Barad DH, Weghofer A, Himaya E, Lee
HJ, Wu YG, Shohat-Tal A, Lazzaroni-Tealdi E, Gleicher N
Universitätsklinik für Frauenheilkunde | 221
Utilizing FMR1 gene mutations as predictors of treatment
success in human in vitro fertilization.
PLoS One. 2014; Jul 14;9(7):e102274 IF: 3,534
Gleicher N, Kushnir VA, Weghofer A, Barad DH
The „graying“ of infertility services: an impending revoluti-
on nobody is ready for.
Reprod Biol Endocrinol. 2014; Jul 9;12:63 IF: 2,409
Wild J, Pateisky P, Küssel L, Huf W, Ott J, Haslinger P,
Knöfler M, Zeisler H
Preeclampsia - a risk factor for osteoporosis? Analysis of
maternal Sclerostin levels and markers of bone turnover in
patients with pre-eclampsia.
Hypertens Pregnancy. 2014; Aug;33(3):333-40 IF: 1,192
Haschka J, Kocijan R, Muschitz C, Patsch JM, Hans D, Zen-
deli A, Bittighofer C, Wild J, Resch H
Trabecular Bone Score and Hip Geometry in Relation to
Body Composition and Biochemical Markers in Women
with Severe Anoerexia Nervosa.
Journal of Clinical Densitometry. 2014; Jul;17(3):404
IF: 1,603
Machherndl-Spandl S, Sega W, Bösmüller H, Germing U, Gru-
ber CH, Nachtkamp K, Reinecke P, Sperr WR, Wimazal F,
Müllauer L, Sotlar K, Horny HP, Tüchler H, Valent P, Krieger O
Prognostic impact of blast cell counts in dysplastic bone
marrow disorders (MDS and CMML I) with concomitant
fibrosis.
Ann Hematol. 2014; 93:57-64 IF: 2,396
Hörmann G, Gleixner KV, Dinu GE, Kundi M, Greiner G, Wi-
mazal F, Hadzijusufovic E, Mitterbauer G, Mannhalter C,
Valent P, Sperr WR
The KIT D816V allele burden predicts survival in patients
with mastocytosis and correlates with the WHO type of the
disease.
Allergy. 2014; 69:810-813 IF: 5,995
Bammer C, Sperr WR, Kemmler G, Wimazal F, Nösslin-
ger T, Schönmetzler A, Krieger O, Pfeilstöcker M, Valent P,
Stauder R
Clustering of comorbidities is related to age and sex and
impacts clinical outcome in myelodysplastic syndromes.
J Geriatr Oncol. 2014; 5:299-306 IF: 1,146
Schuit E, Stock S, Rode L, Rouse D, Lim A, Norman J, Nas-
sar A, Serra V, Combs S, Vayssiere C, Aboulghar M, Wood
S, Cetingöz E, Briery C, Fonseca E, Worda K, Tabor A,
Thom E, Caritis S, Awwad J, Usta I, Perales A, Meseguer J,
Maurel K, Garite T, Aboulghar M, Amin Y, Ross S, Cam C,
Karateke A, Morrison J, Magann E, Nicolaides K, Zuithoff N,
Groenwold R, Moons K, Kwee A, Mol B; a Global Obstetrics
Network (GONet) collaboration
Effectiveness of progestogens to improve perinatal out-
come in twin pregnancies: an individual participant data
meta-analysis.
BJOG. 2014; Aug 22 IF: 3,862
Wagner N, Kagan KO, Haen S, Schmidt S, Yerlikaya G,
Maden Z, Jahn G, Hamprecht K
Effective management and intrauterine treatment of con-
genital cytomegalovirus infection: review article and case
series.
J Matern Fetal Neonatal Med. 2014; Jan;27(2):209-14
IF: 1,208
Yerlikaya G, Laml T, Elenskaia K, Hanzal E, Kölbl H,
Umek W
Pain perception during outpatient cystoscopy: a prospecti-
ve controlled study.
Eur J Obstet Gynecol Reprod Biol. 2014; Feb;173:101-5
IF: 1,627
Ruscito I, Dimitrova D, Vasconcelos I, Gellhaus K,
Schwachula T, Bellati F, Zeillinger R, Benedetti-Panici P,
Vergote I, Mahner S, Cacsire-Tong D, Concin N,
Darb-Esfahani S, Lambrechts S, Sehouli J, Olek S, Braicu EI
BRCA1 gene promoter methylation status in high-grade
serous ovarian cancer patients--a study of the tumour Bank
ovarian cancer (TOC) and ovarian cancer diagnosis consor-
tium (OVCAD).
Eur J Cancer. 2014; Aug;50(12):2090-8 IF: 4,819
Bajari TM, Winnicki W, Gensberger ET, Scharrer SI, Regele
H, Aumayr K, Kopecky C, Gmeiner BM, Hermann M, Zeil-
linger R, Sengölge G
Known players, new interplay in atherogenesis: Chronic
shear stress and carbamylated-LDL induce and modulate
expression of atherogenic LR11 in human coronary artery
endothelium.
Thromb Haemost. 2014; Feb;111(2):323-32 IF: 5,760
Schirmer U, Doberstein K, Rupp AK, Bretz NP, Wuttig D,
Kiefel H, Breunig C, Fiegl H, Müller-Holzner E, Zeillinger R,
Schuster E, Zeimet AG, Sültmann H, Altevogt P
Role of miR-34a as a suppressor of L1CAM in endometrial
carcinoma.
Oncotarget. 2014; Jan 30;5(2):462-72 IF: 6,627
Dröge L1, Herraìz I, Zeisler H, Schlembach D, Stepan H,
Küssel L, Henrich W, Galindo A, Verlohren S
Maternal serum s-Flt-1/PlGF-ratio in twin pregnancies with
and without preeclampsia in comparison to singleton preg-
nancies.
Ultrasound Obstet Gynecol. 2014; Dec;10 IF: 3,140
Verlohren S, Herraiz I, Lapaire O, Schlembach D, Zeisler
H, Calda P, Sabria J, Markfeld-Erol F, Galindo A, Schoofs K,
Denk B, Stepan H
New gestational phase-specific cutoff values for the use
222 | Universitätsklinik für Frauenheilkunde
of the soluble fms-like tyrosine kinase-1/placental growth
factor ratio as a diagnostic test for preeclampsia.
Hypertension. 2014; Feb;63(2):346-52 IF: 7,632
IMPAKTFAKTOR GESAMT: IF: 593,145
IMPAKTFAKTOR ERSTAUTOREN: IF: 162,547
IMPAKTFAKTOR CO-AUTOREN: IF: 430,598